Surface-Available HER2 Levels Alone Are Not Indicative of Cell Response to HER2-Targeted Antibody–Drug Conjugate Therapies is a research paper published in Pharmaceutics (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R21CA256460
National Institutes of Health
Grant: 5R21CA256460-02
Tumor-specific drug activation by pericellular proteases
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals